RNAseq Analysis of Microbial Gene Expression in Necrotizing Soft Tissue Infections



Status:Recruiting
Conditions:Skin and Soft Tissue Infections, Infectious Disease
Therapuetic Areas:Dermatology / Plastic Surgery, Immunology / Infectious Diseases
Healthy:No
Age Range:18 - Any
Updated:1/10/2019
Start Date:December 2013
End Date:December 2019
Contact:Kendra Rumbaugh, PhD
Email:kendra.rumbaugh@ttuhsc.edu
Phone:806-743-2460

Use our guide to learn which trials are right for you!

Hypothesis: We hypothesize that RNAseq will allow us to learn more about the causative agents
of necrotizing soft tissue infections (NSTI) and risk factors involved in acquiring these
devastating infections

Tissue biopsies will be obtained from consented patients admitted with NSTI. Biopsies will be
used for standard clinical analysis of bacterial species present or stored for later RNA
sequencing. RNA sequencing will identify bacteria that are present within the infection site
that may not be detected using standard culture techniques as well as reveal bacterial gene
expression profiles within the NSTI site. Medical charts will also be reviewed for basic
patient information as well as wound care management practices. We hope to identify bacterial
species commonly present in these types of infections as well as risk factors predisposing
individuals to NSTI's.


Inclusion Criteria:

- Patient or LAR agrees to the procedure and signs informed consent form

- Patient is at least 18 yrs of age

- Patient has been diagnosed with an NSTI

Exclusion Criteria:

- Patient not willing to undergo additional tissue biopsies for RNA sequencing analysis
We found this trial at
2
sites
Lubbock, Texas 79430
?
mi
from
Lubbock, TX
Click here to add this to my saved trials
Lubbock, Texas 79430
Principal Investigator: Kendra Rumbaugh, PhD
Phone: 806-743-2460
?
mi
from
Lubbock, TX
Click here to add this to my saved trials